|
US5730723A
(en)
*
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US6474369B2
(en)
|
1995-05-26 |
2002-11-05 |
Penjet Corporation |
Apparatus and method for delivering a lyophilized active with a needle-less injector
|
|
US6223786B1
(en)
|
1998-11-14 |
2001-05-01 |
Pen Jet Corporation |
Apparatus and method for mixing medication and filling an ampule of a needle-less injector
|
|
FR2739562B1
(fr)
*
|
1995-10-09 |
1998-04-24 |
Moreau Defarges Alain |
Dispositif d'injection par jet sans aiguille, comportant une cartouche surmoulee
|
|
US6080130A
(en)
*
|
1998-11-14 |
2000-06-27 |
Castellano; Thomas P. |
Gas power source for a needle-less injector
|
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US6004287A
(en)
*
|
1997-09-23 |
1999-12-21 |
Loomis; Dale J |
Biolistic apparatus for delivering substances into cells and tissues
|
|
DE19820172A1
(de)
*
|
1997-09-30 |
2005-01-27 |
Wolfgang Wagner |
Einrichtung und einrichtungsbezogenes Verfahren zur Einbringung eines Diagnostikträgers oder einer Arznei unter die Haut eines Lebewesens
|
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
|
US6156008A
(en)
*
|
1998-05-04 |
2000-12-05 |
Castellano; Thomas P. |
Device for avoiding subdermal hematomas from an injection
|
|
WO2000006227A1
(en)
*
|
1998-07-27 |
2000-02-10 |
Medi-Ject Corporation |
Loading mechanism for medical injector assembly
|
|
US6783509B1
(en)
|
1998-11-18 |
2004-08-31 |
Bioject Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
|
US6689093B2
(en)
|
1998-11-18 |
2004-02-10 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
|
US6406455B1
(en)
*
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
|
DE19859137C1
(de)
*
|
1998-12-21 |
2000-05-18 |
Ferton Holding Sa |
Ejektionsgerät zur Hochdruckejektion einer Flüssigkeit
|
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
|
WO2000064514A1
(en)
*
|
1999-04-22 |
2000-11-02 |
Gilbert Garitano |
Needleless permanent makeup and tattoo device
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
WO2000072908A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Microheart, Inc. |
Devices and methods for delivering a drug
|
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
|
US20010027293A1
(en)
*
|
1999-06-29 |
2001-10-04 |
Ashok V. Joshi |
Storage stable fluid injection device and associated process
|
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
|
ATE285806T1
(de)
|
1999-10-11 |
2005-01-15 |
Felton International Inc |
Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
|
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
|
FI115664B
(fi)
*
|
1999-10-20 |
2005-06-15 |
Uponor Innovation Ab |
Liitosyhde
|
|
US6673035B1
(en)
|
1999-10-22 |
2004-01-06 |
Antares Pharma, Inc. |
Medical injector and medicament loading system for use therewith
|
|
FR2800619B1
(fr)
*
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
Seringue sans aiguille avec un moyen de poussee temporairement retenu
|
|
US6254579B1
(en)
*
|
1999-11-08 |
2001-07-03 |
Allergan Sales, Inc. |
Multiple precision dose, preservative-free medication delivery system
|
|
DE19955201A1
(de)
*
|
1999-11-16 |
2001-05-31 |
Roesch Ag Medizintechnik |
Injektionseinrichtung
|
|
CA2392598C
(en)
*
|
1999-11-23 |
2010-06-08 |
Needleless Ventures, Inc. |
Injector assembly with driving means and locking means
|
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
|
CA2396569C
(en)
*
|
2000-01-07 |
2010-03-23 |
Biovalve Technologies, Inc. |
Injection device
|
|
US6210359B1
(en)
|
2000-01-21 |
2001-04-03 |
Jet Medica, L.L.C. |
Needleless syringe
|
|
FR2804869B1
(fr)
*
|
2000-02-11 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille pour l'injection d'un liquide contenu dans une ampoule pre-remplie
|
|
WO2001070309A1
(en)
*
|
2000-03-23 |
2001-09-27 |
Antares Pharma, Inc. |
Single use disposable jet injector
|
|
FR2809626B1
(fr)
*
|
2000-05-30 |
2003-03-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille avec membrane d'isolation d'un ejecteur multiconduit
|
|
US6629958B1
(en)
|
2000-06-07 |
2003-10-07 |
Ronald P. Spinello |
Leak sealing needle
|
|
US6406456B1
(en)
|
2000-06-08 |
2002-06-18 |
Avant Drug Delivery Systems, Inc. |
Jet injector
|
|
DE10029325A1
(de)
*
|
2000-06-20 |
2002-01-03 |
Peter Lell |
Nadellose Injektionsvorrichtung mit pyrotechnischem Antrieb
|
|
FR2810554B1
(fr)
*
|
2000-06-22 |
2003-05-16 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un reservoir modulable
|
|
FR2812202B1
(fr)
*
|
2000-07-28 |
2002-09-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par mise en compression du reservoir contenant le principe actif liquide
|
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2324045A1
(fr)
*
|
2000-10-20 |
2002-04-20 |
Universite De Sherbrooke |
Seringue sans aiguille pour l'injection sous-cutanee de poudres medicamenteuses
|
|
US8071740B2
(en)
*
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
|
US7931614B2
(en)
*
|
2000-11-30 |
2011-04-26 |
Valeritas, Inc. |
Injection systems
|
|
EP2281573A3
(en)
|
2001-02-23 |
2011-12-07 |
GlaxoSmithKline Biologicals s.a. |
Influenza vaccine formulations for intradermal delivery
|
|
US6471669B2
(en)
*
|
2001-03-05 |
2002-10-29 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
|
US6645170B2
(en)
|
2001-03-05 |
2003-11-11 |
Bioject Medical Technologies, Inc. |
Simplified disposable needle-free injection apparatus and method
|
|
CA2440983A1
(en)
|
2001-03-14 |
2002-09-26 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
|
MXPA03009385A
(es)
|
2001-04-13 |
2004-11-12 |
Penjet Corp |
Inyector modular libre de aguja, presurizado con gas.
|
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
|
US20040035491A1
(en)
|
2002-08-26 |
2004-02-26 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
|
US6755220B2
(en)
|
2001-04-27 |
2004-06-29 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
|
US6752781B2
(en)
*
|
2001-06-08 |
2004-06-22 |
Sergio Landau |
Durable hypodermic jet injector apparatus and method
|
|
CN1253220C
(zh)
|
2001-06-29 |
2006-04-26 |
贝克顿迪肯森公司 |
通过微管在真皮内输入疫苗和基因治疗剂
|
|
US7544188B2
(en)
*
|
2001-07-19 |
2009-06-09 |
Intelliject, Inc. |
Medical injector
|
|
CN100506284C
(zh)
|
2001-10-19 |
2009-07-01 |
脉管生物生长有限公司 |
多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
|
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
|
US6607510B2
(en)
|
2001-11-09 |
2003-08-19 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
|
DE10155344A1
(de)
*
|
2001-11-10 |
2003-05-28 |
Schott Glas |
Behältnissystem zur nadellosen Injektion von medizinisch wirksamen Substanzen
|
|
PT2308888T
(pt)
|
2001-11-14 |
2017-05-03 |
Janssen Biotech Inc |
Anticorpos anti-il-6, composições, métodos e utilizações
|
|
EP1470161A1
(en)
*
|
2002-01-18 |
2004-10-27 |
Inovio AS |
Bispecific antibody dna constructs for intramuscular administration
|
|
CA2475573C
(en)
|
2002-02-11 |
2013-03-26 |
Antares Pharma, Inc. |
Intradermal injector
|
|
WO2003074102A2
(en)
*
|
2002-03-04 |
2003-09-12 |
Nano Pass Technologies Ltd. |
Devices and methods for transporting fluid across a biological barrier
|
|
GB0206560D0
(en)
|
2002-03-20 |
2002-05-01 |
Glaxo Group Ltd |
Novel device
|
|
WO2003088893A2
(en)
*
|
2002-04-19 |
2003-10-30 |
Equidyne Systems, Inc. |
Multi-component ampule
|
|
ES2368040T3
(es)
*
|
2002-06-10 |
2011-11-11 |
Intervet International Bv |
Inyector sin aguja.
|
|
CA2490409A1
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
|
JP4234675B2
(ja)
*
|
2002-07-11 |
2009-03-04 |
テクファーマ・ライセンシング・アクチェンゲゼルシャフト |
無針注射装置
|
|
US7081109B2
(en)
*
|
2002-08-22 |
2006-07-25 |
Baxa Corporation |
Sterile docking apparatus and method
|
|
US7018356B2
(en)
|
2002-10-31 |
2006-03-28 |
Wise Roger R |
Method and apparatus for adjusting the contents of a needle-less injector
|
|
FR2852517B1
(fr)
*
|
2003-03-21 |
2005-11-11 |
|
Dispositif d'injection sans aiguille a cartouche pyrotechnique et procede d'assemblage d'un tel dispositif
|
|
CA2526362C
(en)
*
|
2003-05-20 |
2012-10-09 |
James F. Collins |
Ophthalmic drug delivery system
|
|
US8545463B2
(en)
*
|
2003-05-20 |
2013-10-01 |
Optimyst Systems Inc. |
Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
|
|
WO2005026375A2
(en)
|
2003-05-22 |
2005-03-24 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
|
EP1635896A1
(en)
*
|
2003-06-20 |
2006-03-22 |
Allergan, Inc. |
Needless injectors
|
|
US20070293447A1
(en)
*
|
2003-08-29 |
2007-12-20 |
Yasuo Kunugiza |
Gene Therapy for Skin Disorders Using Needleless Syringes
|
|
WO2005034949A1
(en)
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
|
IL157981A
(en)
|
2003-09-17 |
2014-01-30 |
Elcam Medical Agricultural Cooperative Ass Ltd |
Auto injector
|
|
IL157984A
(en)
|
2003-09-17 |
2015-02-26 |
Dali Medical Devices Ltd |
Automatic needle
|
|
ES2586387T3
(es)
|
2003-11-05 |
2016-10-14 |
Dana-Farber Cancer Institute, Inc. |
Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
|
|
EP1699524A4
(en)
*
|
2003-11-18 |
2009-07-15 |
Nanopass Technologies Ltd |
Enhanced penetration system and method for sliding microneedles
|
|
EP1689465A4
(en)
*
|
2003-12-05 |
2011-10-12 |
Zogenix Inc |
DEVICE FOR DELIVERY OF A NEEDLELESS INJECTOR USED FOR DRUG DELIVERY
|
|
EP1722842A1
(en)
*
|
2004-01-26 |
2006-11-22 |
The Medical House Plc |
Needle-free injection device
|
|
US7717879B2
(en)
*
|
2004-02-03 |
2010-05-18 |
Smjm Inject Gmbh |
Anesthetic syringe
|
|
US7347851B1
(en)
|
2004-03-09 |
2008-03-25 |
Leo B Kriksunov |
Needleless hypodermic jet injector apparatus and method
|
|
IL160891A0
(en)
|
2004-03-16 |
2004-08-31 |
|
Auto-mix needle
|
|
US20070135338A1
(en)
*
|
2004-03-31 |
2007-06-14 |
Karyn O'neil |
Human GLP-1 mimetibodies, compositions, methods and uses
|
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
|
JP2008506447A
(ja)
|
2004-07-14 |
2008-03-06 |
バイ−パス， インコーポレイテッド |
材料送達システム
|
|
US9180426B2
(en)
|
2004-07-29 |
2015-11-10 |
Gas Technologies, Llc |
Scrubber for methanol production system
|
|
US7910787B2
(en)
*
|
2004-07-29 |
2011-03-22 |
Gas Technologies Llc |
Method and system for methanol production
|
|
US7642293B2
(en)
|
2004-07-29 |
2010-01-05 |
Gas Technologies Llc |
Method and apparatus for producing methanol with hydrocarbon recycling
|
|
US7393662B2
(en)
*
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
NZ553776A
(en)
|
2004-09-22 |
2010-05-28 |
Glaxosmithkline Biolog Sa |
Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
|
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
US7648483B2
(en)
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
|
US10737028B2
(en)
|
2004-11-22 |
2020-08-11 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
|
US11590286B2
(en)
|
2004-11-22 |
2023-02-28 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
|
EP1814611A4
(en)
|
2004-11-22 |
2010-06-02 |
Intelliject Inc |
DEVICES, SYSTEMS AND METHOD FOR DISTRIBUTING A MEDICAMENT
|
|
US7648482B2
(en)
*
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems, and methods for medicament delivery
|
|
US7947017B2
(en)
*
|
2004-11-22 |
2011-05-24 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
|
BRPI0515759B8
(pt)
*
|
2004-12-01 |
2021-06-22 |
Acushot Inc |
dispositivo de injeção sem agulha e kit para utilização do mesmo
|
|
CN101132820B
(zh)
|
2005-01-24 |
2010-05-19 |
安塔雷斯制药公司 |
预充式针辅助喷射注入器
|
|
US8231573B2
(en)
|
2005-02-01 |
2012-07-31 |
Intelliject, Inc. |
Medicament delivery device having an electronic circuit system
|
|
US7731686B2
(en)
|
2005-02-01 |
2010-06-08 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
|
US9022980B2
(en)
|
2005-02-01 |
2015-05-05 |
Kaleo, Inc. |
Medical injector simulation device
|
|
US8206360B2
(en)
|
2005-02-01 |
2012-06-26 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
|
US8361026B2
(en)
|
2005-02-01 |
2013-01-29 |
Intelliject, Inc. |
Apparatus and methods for self-administration of vaccines and other medicaments
|
|
GB2451769B
(en)
|
2005-02-01 |
2009-12-09 |
Intelliject Llc |
Devices, systems, and methods for medicament delivery
|
|
AR054020A1
(es)
|
2005-03-23 |
2007-05-30 |
Glaxosmithkline Biolog Sa |
Nuevo uso
|
|
BRPI0610644B8
(pt)
|
2005-04-04 |
2021-05-25 |
Univ Florida |
composto e composição farmacêutica que compreende tal composto e um veículo ou diluente farmaceuticamente aceitável.
|
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
|
US7611505B2
(en)
*
|
2005-05-10 |
2009-11-03 |
Baxa Corporation |
Sterile docking apparatus and method
|
|
SI2452694T1
(sl)
|
2005-06-30 |
2019-05-31 |
Janssen Biotech, Inc. |
Protitelesa proti-IL-23, sestavki in postopki uporabe
|
|
JP2009502207A
(ja)
|
2005-08-03 |
2009-01-29 |
フラウンホーファー ユーエスエー， インコーポレイテッド |
イムノグロブリンの産生のための組成物および方法
|
|
US8591457B2
(en)
*
|
2005-08-10 |
2013-11-26 |
Alza Corporation |
Method for making a needle-free jet injection drug delivery device
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
KR101515078B1
(ko)
|
2005-12-22 |
2015-04-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
백신
|
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
|
BRPI0707733B1
(pt)
|
2006-02-13 |
2019-12-31 |
Ibio, Inc. |
antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno
|
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
|
EP2476433A1
(en)
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
US20100034819A1
(en)
*
|
2006-03-31 |
2010-02-11 |
Centocor Inc. |
Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia
|
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
|
US20070254381A1
(en)
*
|
2006-04-27 |
2007-11-01 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Monitoring and/or treating syringe mechanism
|
|
WO2007131013A1
(en)
|
2006-05-03 |
2007-11-15 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
|
US20070260174A1
(en)
*
|
2006-05-05 |
2007-11-08 |
Searete Llc |
Detecting a failure to maintain a regimen
|
|
USD571912S1
(en)
|
2006-05-10 |
2008-06-24 |
Baxa Corporation |
Medical connector docking device
|
|
JP5630998B2
(ja)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
|
EP2030015B1
(en)
|
2006-06-02 |
2016-02-17 |
President and Fellows of Harvard College |
Protein surface remodeling
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
PT2422810E
(pt)
|
2006-07-17 |
2014-12-03 |
Glaxosmithkline Biolog Sa |
Vacina da gripe
|
|
US9115358B2
(en)
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
|
DE202006018609U1
(de)
*
|
2006-08-29 |
2007-05-16 |
Euro-Celtique S.A. |
Verwendung von Opioidformulierungen in nadellosen Vorrichtungen zur Medikamentenverabreichung
|
|
US7547293B2
(en)
*
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
EP2433648A3
(en)
|
2006-10-12 |
2012-04-04 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
|
EA015817B1
(ru)
|
2006-10-12 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
|
|
DE202006017522U1
(de)
*
|
2006-11-15 |
2007-01-18 |
Perma-Tec Gmbh & Co. Kg |
Schmierstoffspender
|
|
SG177184A1
(en)
|
2006-12-01 |
2012-01-30 |
Anterios Inc |
Amphiphilic entity nanoparticles
|
|
US20080140001A1
(en)
*
|
2006-12-12 |
2008-06-12 |
By-Pass Inc. |
Fluid Delivery Apparatus And Methods
|
|
AR064623A1
(es)
*
|
2006-12-21 |
2009-04-15 |
Centocor Inc |
Uso de agonistas del receptor de glp -1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
|
|
ES2405655T3
(es)
|
2006-12-26 |
2013-05-31 |
Lantheus Medical Imaging, Inc. |
N-[3-bromo-4-(3-[18F]fluoropropoxi)-bencil]-guanidina para la formación de imágenes de la inervación cardíaca
|
|
US20080171968A1
(en)
*
|
2007-01-15 |
2008-07-17 |
Bioject, Inc. |
Methods of administering injectables to a joint with a needle-free injection system
|
|
WO2008091838A2
(en)
|
2007-01-22 |
2008-07-31 |
Intelliject, Inc. |
Medical injector with compliance tracking and monitoring
|
|
DK2118123T3
(en)
|
2007-01-31 |
2016-01-25 |
Dana Farber Cancer Inst Inc |
Stabilized p53 peptides and uses thereof
|
|
EP2134830A2
(en)
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
|
US7744563B2
(en)
*
|
2007-02-23 |
2010-06-29 |
Bioject, Inc. |
Needle-free injection devices and drug delivery systems therefor
|
|
JP5439193B2
(ja)
|
2007-03-15 |
2014-03-12 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． |
デスフェリチオシンポリエーテル類似体
|
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
EP2152301A4
(en)
|
2007-04-28 |
2010-07-28 |
Fraunhofer Usa Inc |
TRYPANOSOMAANTIGEN, VACCINE COMPOSITIONS AND RELATED METHODS
|
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
|
CA2690708A1
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
WO2009009759A2
(en)
|
2007-07-11 |
2009-01-15 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
EP2205074A4
(en)
|
2007-10-04 |
2013-07-31 |
Harvard College |
MOENOMYCIN ANALOGUE, SYNTHESIS PROCESS AND USE
|
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
PL2214699T3
(pl)
|
2007-11-02 |
2017-05-31 |
Grifols Therapeutics Inc. |
Sposób, kompozycja i wyrób do dostarczania alfa1-antytrypsyny
|
|
US9533098B2
(en)
|
2007-11-19 |
2017-01-03 |
Painless Tech Gmbh |
Injection device for the needle-free injection of a medium
|
|
USD596290S1
(en)
*
|
2007-12-25 |
2009-07-14 |
Daikyo Seiko, Ltd. |
Syringe barrel body cover
|
|
WO2009089119A2
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
|
US20090212133A1
(en)
*
|
2008-01-25 |
2009-08-27 |
Collins Jr James F |
Ophthalmic fluid delivery device and method of operation
|
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
ES2553113T3
(es)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vacuna
|
|
US8021344B2
(en)
|
2008-07-28 |
2011-09-20 |
Intelliject, Inc. |
Medicament delivery device configured to produce an audible output
|
|
USD994111S1
(en)
|
2008-05-12 |
2023-08-01 |
Kaleo, Inc. |
Medicament delivery device cover
|
|
US20090291986A1
(en)
|
2008-05-22 |
2009-11-26 |
Apostolos Pappas |
Composition and method of treating facial skin defect
|
|
KR101848095B1
(ko)
|
2008-06-26 |
2018-04-11 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
ES2442024T3
(es)
|
2008-07-15 |
2014-02-07 |
Academia Sinica |
Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
|
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
LIGURE COMBINED POLYPEPTIDES
|
|
EP3581224A1
(en)
|
2008-08-05 |
2019-12-18 |
Antares Pharma, Inc. |
Multiple dosage injector
|
|
KR20160116056A
(ko)
|
2008-08-14 |
2016-10-06 |
테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 |
항-ｉｌ-12/ｉｌ-23 항체
|
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
|
CA2737461A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
DE102008048595A1
(de)
|
2008-09-23 |
2010-04-01 |
Lts Lohmann Therapie-Systeme Ag |
Einweginjektor mit hoher Injektionssicherheit
|
|
US8663196B2
(en)
*
|
2008-09-23 |
2014-03-04 |
Kassab Kughn Endovascular Devices Llc |
Endovascular sheath with gradable stiffness device and method
|
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
ES2705714T3
(es)
|
2008-10-31 |
2019-03-26 |
Janssen Biotech Inc |
Métodos y usos de dominio de Fibronectina tipo III basado en estructuras de composiciones
|
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
US9637746B2
(en)
|
2008-12-15 |
2017-05-02 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
|
US9175047B2
(en)
|
2009-01-14 |
2015-11-03 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
BRPI1008532B1
(pt)
|
2009-02-12 |
2021-12-14 |
Janssen Biotech, Inc |
Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos
|
|
AU2010226442A1
(en)
|
2009-03-20 |
2011-10-13 |
Antares Pharma, Inc. |
Hazardous agent injection system
|
|
IL197761A0
(en)
*
|
2009-03-23 |
2009-12-24 |
Moshe Zalsman |
Capsule for mixing together two flowable materials, and kits including such capsules, particularly useful in dentistry
|
|
EP2424877A4
(en)
|
2009-04-28 |
2013-01-02 |
Harvard College |
SUPRAGELADENE PROTEINS FOR CELL PENETRATION
|
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8927551B2
(en)
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
WO2010141074A2
(en)
|
2009-06-01 |
2010-12-09 |
President And Fellows Of Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
|
AU2010273220B2
(en)
|
2009-07-13 |
2015-10-15 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
US8926561B2
(en)
|
2009-07-30 |
2015-01-06 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
EP2298390A1
(en)
*
|
2009-08-28 |
2011-03-23 |
Sanofi-Aventis Deutschland GmbH |
Medical delivery device, housing cap for a medical delivery device and drive mechanism for a medical delivery device
|
|
CN102712675A
(zh)
|
2009-09-22 |
2012-10-03 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
US8784819B2
(en)
|
2009-09-29 |
2014-07-22 |
Ibio Inc. |
Influenza hemagglutinin antibodies, compositions and related methods
|
|
US20140200511A1
(en)
*
|
2009-10-30 |
2014-07-17 |
Searete Llc |
Systems, devices, and methods for making or administering frozen particles
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
AU2011210840B2
(en)
|
2010-01-27 |
2014-12-11 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
|
RU2015143910A
(ru)
|
2010-02-03 |
2018-12-28 |
Инфинити Фармасьютикалз, Инк. |
Ингибиторы амид-гидролазы жирных кислот
|
|
EP2533814A2
(en)
*
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
AU2011224457B2
(en)
|
2010-03-08 |
2014-11-06 |
Sloan-Kettering Institute For Cancer Research |
Cdc7 kinase inhibitors and uses thereof
|
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
|
EP2550285B1
(en)
|
2010-03-22 |
2017-07-19 |
President and Fellows of Harvard College |
Trioxacarcins and uses thereof
|
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
|
CA2798330A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
|
EP2566953B1
(en)
|
2010-05-07 |
2019-01-02 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
|
ES2763815T3
(es)
|
2010-05-11 |
2020-06-01 |
Lantheus Medical Imaging Inc |
Composiciones, métodos y sistemas para la síntesis y uso de agentes de formación de imágenes
|
|
EP2571875A4
(en)
|
2010-05-14 |
2013-10-30 |
Dana Farber Cancer Inst Inc |
CONTRACEPTIVE COMPOSITIONS FOR MEN AND METHODS OF USE THEREOF
|
|
WO2011160042A2
(en)
|
2010-06-18 |
2011-12-22 |
Makoto Life Sciences, Inc. |
Prpk-tprkb modulators and uses thereof
|
|
EP3323830B1
(en)
|
2010-06-19 |
2023-08-23 |
Memorial Sloan-Kettering Cancer Center |
Anti-gd2 antibodies
|
|
EP2485691B1
(en)
|
2010-07-15 |
2020-03-18 |
Eyenovia, Inc. |
Ophthalmic drug delivery
|
|
AU2011278934B2
(en)
|
2010-07-15 |
2015-02-26 |
Eyenovia, Inc. |
Drop generating device
|
|
JP2013531548A
(ja)
|
2010-07-15 |
2013-08-08 |
コリンシアン オフサルミック，インコーポレイティド |
遠隔治療及び遠隔モニタリングを実施する方法及びシステム
|
|
US10154923B2
(en)
|
2010-07-15 |
2018-12-18 |
Eyenovia, Inc. |
Drop generating device
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
EP2611922A1
(en)
|
2010-08-31 |
2013-07-10 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
|
JP2013541528A
(ja)
|
2010-09-21 |
2013-11-14 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
JP6029586B2
(ja)
|
2010-10-04 |
2016-11-24 |
マサチューセッツ インスティテュート オブ テクノロジー |
血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
GB201021716D0
(en)
*
|
2010-12-22 |
2011-02-02 |
Owen Mumford Ltd |
Autoinjectors
|
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
|
BR112013017561A2
(pt)
*
|
2011-01-10 |
2016-10-11 |
Zogenix Inc |
injetores sem agulha aperfeiçoados
|
|
EP3378480A1
(en)
|
2011-01-19 |
2018-09-26 |
Topokine Therapeutics, Inc. |
Methods and compositions for treating obesity
|
|
US20120328701A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Nanoparticle compositions, formulations thereof, and uses therefor
|
|
US20120328549A1
(en)
|
2011-01-24 |
2012-12-27 |
Anterios, Inc. |
Oil compositions
|
|
BR112013018918A2
(pt)
|
2011-01-24 |
2016-10-04 |
Anterios Inc |
composições de nanopartículas
|
|
US9084849B2
(en)
|
2011-01-26 |
2015-07-21 |
Kaleo, Inc. |
Medicament delivery devices for administration of a medicament within a prefilled syringe
|
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
|
CN103889219A
(zh)
|
2011-03-03 |
2014-06-25 |
特萨斯制药有限责任公司 |
包含C16:1n7-棕榈油酸酯的组合物和方法
|
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
|
WO2012135615A2
(en)
|
2011-03-30 |
2012-10-04 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
CN103533953A
(zh)
|
2011-05-17 |
2014-01-22 |
葛兰素史密丝克莱恩生物有限公司 |
针对肺炎链球菌的疫苗
|
|
FR2976568B1
(fr)
|
2011-06-14 |
2014-09-05 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
US8672883B2
(en)
|
2011-07-11 |
2014-03-18 |
C. Garyen Denning |
Fluid delivery device and methods
|
|
US9220660B2
(en)
|
2011-07-15 |
2015-12-29 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
|
US8496619B2
(en)
|
2011-07-15 |
2013-07-30 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
|
AR088218A1
(es)
|
2011-07-19 |
2014-05-21 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos utiles como inhibidores de pi3k
|
|
HK1198443A1
(en)
|
2011-07-19 |
2015-04-24 |
无限药品股份有限公司 |
Heterocyclic compounds and uses thereof
|
|
SI2734510T1
(sl)
|
2011-07-22 |
2019-05-31 |
Massachusetts Institute Of Technology |
Aktivatorji histon deacetilaz (HDACS) razreda I in njihove uporabe
|
|
MX2014002542A
(es)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|
|
CN104093848A
(zh)
|
2011-09-09 |
2014-10-08 |
绿光生物科学公司 |
碳青霉烯(carbapenem)的无细胞制备
|
|
CN108484449A
(zh)
|
2011-09-09 |
2018-09-04 |
蓝瑟斯医学影像公司 |
用于合成和使用显像剂的组合物、方法和系统
|
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
US9382239B2
(en)
|
2011-11-17 |
2016-07-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-Jun-N-terminal kinase (JNK)
|
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
JP6105621B2
(ja)
|
2011-12-12 |
2017-03-29 |
アイノビア，インコーポレイティド |
高弾性高分子エジェクタ機構、エジェクタ装置及びそれらの使用方法
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
US9273084B2
(en)
|
2012-04-06 |
2016-03-01 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
|
JP6457383B2
(ja)
|
2012-04-06 |
2019-01-23 |
アンタレス・ファーマ・インコーポレーテッド |
テストステロン組成物の針支援式ジェット注入投与
|
|
US9902985B2
(en)
|
2012-04-06 |
2018-02-27 |
President And Fellows Of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
US9364610B2
(en)
|
2012-05-07 |
2016-06-14 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
|
SG11201406769RA
(en)
|
2012-05-10 |
2014-11-27 |
Massachusetts Inst Technology |
Agents for influenza neutralization
|
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
|
US9522235B2
(en)
|
2012-05-22 |
2016-12-20 |
Kaleo, Inc. |
Devices and methods for delivering medicaments from a multi-chamber container
|
|
AU2013301312A1
(en)
|
2012-08-06 |
2015-03-19 |
Glaxosmithkline Biologicals S.A. |
Method for eliciting in infants an immune response against RSV and B. pertussis
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
|
WO2014031498A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
|
WO2014042930A1
(en)
*
|
2012-09-17 |
2014-03-20 |
Hns International, Inc. |
Needleless hypodermic injector and related method
|
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
RS58700B1
(sr)
|
2012-10-12 |
2019-06-28 |
Broad Inst Inc |
Gsk3 inhibitori i postupci njihove primene
|
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
US9675754B2
(en)
*
|
2012-10-24 |
2017-06-13 |
Nuance Designs, LLC |
Autoinjector
|
|
AU2013337717B2
(en)
|
2012-11-01 |
2018-10-25 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using PI3 kinase isoform modulators
|
|
WO2014071241A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
|
WO2014081941A1
(en)
|
2012-11-21 |
2014-05-30 |
Topokine Therapeutics, Inc. |
Methods and compositions for locally increasing body fat
|
|
JP6408478B2
(ja)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
DK2935222T3
(en)
*
|
2012-12-21 |
2019-01-07 |
Epizyme Inc |
PRMT5 INHIBITORS AND APPLICATIONS THEREOF
|
|
CA2894126A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CA2899363A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US9745291B2
(en)
|
2012-12-21 |
2017-08-29 |
Epizyme, Inc. |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
|
WO2014106096A1
(en)
|
2012-12-27 |
2014-07-03 |
Kaleo, Inc. |
Devices, systems and methods for locating and interacting with medicament delivery systems
|
|
AU2013374345A1
(en)
|
2013-01-17 |
2015-08-06 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
|
US11576958B2
(en)
|
2013-02-07 |
2023-02-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
|
EP4349383A3
(en)
|
2013-02-11 |
2024-06-19 |
Antares Pharma, Inc. |
Needle assisted jet injection device having reduced trigger force
|
|
EP2968792B1
(en)
|
2013-03-11 |
2019-05-15 |
Antares Pharma, Inc. |
Dosage injector with pinion system
|
|
EP3391898A3
(en)
|
2013-03-13 |
2019-02-13 |
President and Fellows of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
|
RU2680267C2
(ru)
|
2013-03-15 |
2019-02-19 |
Мемориал Слоан Кеттеринг Кэнсер Сентер |
Высокоаффинные антитела к gd2
|
|
WO2014151386A1
(en)
|
2013-03-15 |
2014-09-25 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
|
JP6437523B2
(ja)
|
2013-04-04 |
2018-12-12 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
マクロライドならびにそれらの調製および使用の方法
|
|
WO2014169073A1
(en)
|
2013-04-09 |
2014-10-16 |
Massachusetts Institute Of Technology |
Drug delivery polymer and uses thereof
|
|
WO2014179464A1
(en)
|
2013-04-30 |
2014-11-06 |
Massachusetts Institute Of Technology |
Human adaptation of h3 influenza
|
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
|
NO2753788T3
(https=)
|
2013-05-10 |
2018-06-16 |
|
|
|
WO2014186504A1
(en)
|
2013-05-15 |
2014-11-20 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
|
CA2914284A1
(en)
|
2013-05-30 |
2014-12-04 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
|
CA2914815A1
(en)
|
2013-06-11 |
2014-12-18 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
|
JP2016523241A
(ja)
|
2013-06-14 |
2016-08-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
安定化されたポリペプチドインスリン受容体調節剤
|
|
EP3013365B1
(en)
|
2013-06-26 |
2019-06-05 |
Academia Sinica |
Rm2 antigens and use thereof
|
|
EP3013347B1
(en)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glycan conjugates and use thereof
|
|
US9975896B2
(en)
|
2013-07-25 |
2018-05-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
AU2014306074B2
(en)
|
2013-08-05 |
2018-08-30 |
Greenlight Biosciences, Inc. |
Engineered proteins with a protease cleavage site
|
|
MX2016001695A
(es)
|
2013-08-05 |
2016-05-02 |
Glaxosmithkline Biolog Sa |
Composiciones inmunogenas de combinacion.
|
|
JP6486368B2
(ja)
|
2013-09-06 |
2019-03-20 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
|
|
PT3052485T
(pt)
|
2013-10-04 |
2021-10-22 |
Infinity Pharmaceuticals Inc |
Compostos heterocíclicos e suas utilizações
|
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
|
EP3057956B1
(en)
|
2013-10-18 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
RU2016122654A
(ru)
|
2013-11-08 |
2017-12-14 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Комбинированная терапия злокачественной опухоли с использованием ингибиторов бромодоменового и экстратерминального (вет) белка
|
|
WO2015070712A1
(en)
*
|
2013-11-14 |
2015-05-21 |
Abon Biopharm (Hangzhou) Co., Ltd. |
A device and method for using the device
|
|
AU2014369834B2
(en)
|
2013-12-24 |
2018-12-20 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
AU2015206370A1
(en)
|
2014-01-16 |
2016-07-07 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
JP2017506666A
(ja)
|
2014-02-28 |
2017-03-09 |
テンシャ セラピューティクス，インコーポレイテッド |
高インスリン血症に関連した症状の処置
|
|
MX2016011517A
(es)
|
2014-03-07 |
2017-04-13 |
Univ Arizona |
Peptidos de crmp2 no narcoticos que seleccionan como diana canales de sodio para el dolor cronico.
|
|
JP6296840B2
(ja)
*
|
2014-03-11 |
2018-03-20 |
テルモ株式会社 |
液体投与具
|
|
JP6262030B2
(ja)
*
|
2014-03-11 |
2018-01-17 |
テルモ株式会社 |
液体投与具
|
|
MX382033B
(es)
|
2014-03-19 |
2025-03-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
|
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
|
DK3122375T3
(da)
|
2014-03-28 |
2021-05-25 |
Univ Washington Through Its Center For Commercialization |
Vacciner mod bryst- og ovariecancer
|
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
|
CA2949535C
(en)
|
2014-05-21 |
2023-09-12 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
|
JP7093612B2
(ja)
|
2014-05-27 |
2022-06-30 |
アカデミア シニカ |
Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法
|
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
CN106661099A
(zh)
|
2014-05-27 |
2017-05-10 |
中央研究院 |
抗her2醣抗体及其用途
|
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
|
WO2015184001A1
(en)
|
2014-05-28 |
2015-12-03 |
Academia Sinica |
Anti-tnf-alpha glycoantibodies and uses thereof
|
|
CN111840696B
(zh)
|
2014-06-03 |
2022-12-20 |
安姆根有限公司 |
可控制药物递送系统和使用方法
|
|
MX384992B
(es)
|
2014-06-13 |
2025-03-14 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunógenas.
|
|
EP3778584A1
(en)
|
2014-06-19 |
2021-02-17 |
ARIAD Pharmaceuticals, Inc. |
Production process of 2-chloro-4-heteroaryl-pyrimidine derivatives
|
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
|
EP3164099B1
(en)
*
|
2014-07-15 |
2022-03-23 |
Alcon Inc. |
Intraocular lens inserter with temperature compensation
|
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
|
US10759836B2
(en)
|
2014-07-18 |
2020-09-01 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
|
WO2018140026A1
(en)
|
2017-01-27 |
2018-08-02 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
|
US10736966B2
(en)
|
2014-08-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Brush-poly (glycoamidoamine)-lipids and uses thereof
|
|
CN104162207A
(zh)
*
|
2014-08-27 |
2014-11-26 |
苏州承乐电子科技有限公司 |
一种持续型无针注射器
|
|
TWI745275B
(zh)
|
2014-09-08 |
2021-11-11 |
中央研究院 |
使用醣脂激活人類ｉＮＫＴ細胞
|
|
EP3197478A4
(en)
|
2014-09-24 |
2018-05-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
AU2015320545C1
(en)
|
2014-09-24 |
2020-05-14 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
UA119794C2
(uk)
|
2014-10-21 |
2019-08-12 |
Аріад Фармасьютикалз, Інк. |
Кристалічна форма 5-хлор-n4-[2-(диметилфосфорил)феніл]-n2-{2-метокси-4-[4-(4-метилпіперазин-1-іл)піперидин-1-іл]}піримідин-2,4-діаміну
|
|
KR20170068597A
(ko)
|
2014-10-27 |
2017-06-19 |
텐샤 세러퓨틱스 인코포레이티드 |
브로모도메인 저해제
|
|
EP3212222A2
(en)
|
2014-10-28 |
2017-09-06 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Compositions and methods for antigen-specific tolerance
|
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
|
US10253045B2
(en)
|
2014-11-26 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
|
EP3230272B1
(en)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
|
EP3848072A1
(en)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
EP3237066B1
(en)
|
2014-12-23 |
2020-10-21 |
Sloan-Kettering Institute for Cancer Research |
Polymorph of granaticin b
|
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
新規なグリカンコンジュゲートおよびその使用方法
|
|
SG11201707538XA
(en)
|
2015-03-17 |
2017-10-30 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2016154427A2
(en)
|
2015-03-24 |
2016-09-29 |
Kaleo, Inc. |
Devices and methods for delivering a lyophilized medicament
|
|
USRE50776E1
(en)
|
2015-03-27 |
2026-02-03 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
BR112017020690A2
(pt)
|
2015-03-30 |
2018-06-26 |
Greenlight Biosciences Inc |
produção livre de células de ácido ribonucleico
|
|
EP3288557A4
(en)
|
2015-04-27 |
2018-11-07 |
University of Florida Research Foundation, Inc. |
Metabolically programmed metal chelators and uses thereof
|
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
|
WO2016205691A1
(en)
|
2015-06-19 |
2016-12-22 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
|
US10576206B2
(en)
|
2015-06-30 |
2020-03-03 |
Kaleo, Inc. |
Auto-injectors for administration of a medicament within a prefilled syringe
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
|
WO2017048702A1
(en)
|
2015-09-14 |
2017-03-23 |
Infinity Pharmaceuticals, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
EP3350333B2
(en)
|
2015-09-17 |
2025-08-06 |
ModernaTX, Inc. |
Polynucleotides containing a stabilizing tail region
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
LT3394030T
(lt)
|
2015-12-22 |
2022-04-11 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
|
EP3426693A4
(en)
|
2016-03-08 |
2019-11-13 |
Academia Sinica |
PROCESS FOR MODULAR SYNTHESIS OF N-GLYCANES AND ARRANGEMENTS THEREOF
|
|
US10918808B2
(en)
*
|
2016-03-09 |
2021-02-16 |
Portal Instruments, Inc. |
Angled injection nozzle
|
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
|
CN109071653A
(zh)
|
2016-03-29 |
2018-12-21 |
詹森生物科技公司 |
用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
|
|
CA3020312A1
(en)
|
2016-04-06 |
2017-10-12 |
Greenlight Biosciences, Inc. |
Cell-free production of ribonucleic acid
|
|
WO2017196504A1
(en)
|
2016-05-10 |
2017-11-16 |
Sage Burton H Jr |
Spring-driven drug delivery device
|
|
TWI729141B
(zh)
*
|
2016-05-31 |
2021-06-01 |
德商賽諾菲阿凡提斯德意志有限公司 |
藥物輸送裝置之蓋組合件及其組裝方法
|
|
TW201803615A
(zh)
*
|
2016-05-31 |
2018-02-01 |
賽諾菲阿凡提斯德意志有限公司 |
藥物輸送裝置的按鈕及組裝藥物輸送裝置的按鈕之方法
|
|
EA201892385A1
(ru)
|
2016-06-03 |
2019-06-28 |
Санофи Пастер Инк. |
Модификация сконструированных полипептидов гемагглютинина вируса гриппа
|
|
US10105449B2
(en)
|
2016-06-07 |
2018-10-23 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
RU2019104074A
(ru)
|
2016-07-15 |
2020-08-18 |
Посейда Терапьютикс, Инк. |
Химерные рецепторы антигенов и способы их применения
|
|
WO2018014039A1
(en)
|
2016-07-15 |
2018-01-18 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (cars) specific for muc1 and methods for their use
|
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA3031799A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
|
CA3037961A1
(en)
|
2016-09-30 |
2018-04-05 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il23 specific antibody
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
US11208474B2
(en)
|
2016-11-16 |
2021-12-28 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-IL23 specific antibody
|
|
CN107050580B
(zh)
*
|
2016-11-28 |
2019-12-31 |
大连医科大学附属第二医院 |
带增压功能的自动复位无针注射器
|
|
CN106668992B
(zh)
*
|
2016-11-28 |
2019-07-12 |
合肥讯创信息科技有限公司 |
增压无针注射装置
|
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
|
EP3558420B1
(en)
|
2016-12-23 |
2024-09-18 |
Kaleo, Inc. |
Medicament delivery device and methods for delivering drugs to infants and children
|
|
AU2018210313A1
(en)
|
2017-01-17 |
2019-06-20 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and event detection
|
|
WO2018140121A1
(en)
|
2017-01-30 |
2018-08-02 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
|
|
GB2559553B
(en)
*
|
2017-02-06 |
2021-10-13 |
Consort Medical Plc |
A medicament delivery device
|
|
MX2019009377A
(es)
|
2017-02-07 |
2019-12-11 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa.
|
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
|
JP7227163B2
(ja)
|
2017-06-10 |
2023-02-21 |
アイノビア，インコーポレイティド |
流体を取扱い、目に流体を送出するための方法および装置
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
CN107252512B
(zh)
*
|
2017-06-16 |
2018-03-13 |
南阳市中心医院 |
一种气动无针注射器
|
|
MX2019015524A
(es)
|
2017-06-23 |
2020-09-10 |
Univ Maryland |
Composiciones inmunogenicas.
|
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS AND USES THEREOF
|
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
ANTIMICROBIAL COMPOUNDS
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
BR112020003736A2
(pt)
|
2017-08-22 |
2020-09-08 |
Shire-Nps Pharmaceuticals, Inc. |
polipeptídeos de fusão de glp-2 e usos para tratar e prevenir condições gastrointestinais
|
|
US11318253B2
(en)
*
|
2017-08-29 |
2022-05-03 |
Clear Dart, L.L.C. |
Dart syringe projectile
|
|
EP3675817A1
(en)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
KR101862201B1
(ko)
*
|
2017-08-31 |
2018-05-29 |
제이에스케이바이오메드(주) |
역류방지밸브가 구비된 마이크로젯 약물 주사 장치
|
|
AU2018329741B2
(en)
|
2017-09-08 |
2025-02-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression
|
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗ｉｌ１２／ｉｌ２３抗體治療狼瘡之安全且有效之方法
|
|
KR102894284B1
(ko)
|
2017-10-11 |
2025-12-03 |
그린라이트 바이오사이언시스, 아이엔씨. |
뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
|
|
JP2021502349A
(ja)
|
2017-11-06 |
2021-01-28 |
ヤンセン バイオテツク，インコーポレーテツド |
抗ｉｌ２３特異的抗体で乾癬性関節炎を治療する安全かつ有効な方法
|
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
|
US12415844B2
(en)
|
2017-12-20 |
2025-09-16 |
Poseida Therapeutics, Inc. |
BCMA specific VCAR compositions and methods for use
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
|
EP3749357A4
(en)
|
2018-02-05 |
2022-04-20 |
Sanofi Pasteur, Inc. |
POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
|
|
BR112020014978A2
(pt)
|
2018-02-05 |
2020-12-22 |
Sanofi Pasteur, Inc. |
Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
|
|
KR101859735B1
(ko)
*
|
2018-02-07 |
2018-05-21 |
주식회사 피테크 |
무통 주사 장치
|
|
MX2020009265A
(es)
|
2018-03-05 |
2020-10-01 |
Janssen Biotech Inc |
Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23.
|
|
TWI908706B
(zh)
|
2018-03-07 |
2025-12-21 |
美商波西達治療公司 |
ＣＡＲＴｙｒｉｎ組成物和使用方法
|
|
ES2962544T3
(es)
*
|
2018-04-09 |
2024-03-19 |
Becton Dickinson France |
Sistema de inyección médica
|
|
US20190345245A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
|
US11929160B2
(en)
|
2018-07-16 |
2024-03-12 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and compliance detection
|
|
US20200025776A1
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody
|
|
WO2020047251A1
(en)
|
2018-08-29 |
2020-03-05 |
President And Fellows Of Harvard College |
O-glcnac transferase inhibitors and uses thereof
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
IL326284A
(en)
|
2018-09-24 |
2026-04-01 |
Janssen Biotech Inc |
A safe and effective method for treating ulcerative colitis with an anti-IL12/IL23 antibody
|
|
IL283192B2
(en)
|
2018-11-20 |
2025-10-01 |
Janssen Biotech Inc |
A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody
|
|
MA54562A
(fr)
|
2018-12-18 |
2021-10-27 |
Janssen Biotech Inc |
Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
|
|
CA3124103A1
(en)
|
2018-12-20 |
2020-06-25 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
|
EP3902584A4
(en)
|
2018-12-29 |
2022-09-07 |
Kaleo, Inc. |
DEVICES AND METHODS FOR DELIVERING SUBSTANCES IN A PRE-FILLED SYRINGE
|
|
JP7689074B2
(ja)
|
2019-01-15 |
2025-06-05 |
ヤンセン バイオテツク，インコーポレーテツド |
若年性特発性関節炎の治療のための抗ｔｎｆ抗体、組成物、及び方法
|
|
AU2020209167B2
(en)
|
2019-01-16 |
2025-09-04 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
|
AU2020209170B2
(en)
|
2019-01-16 |
2025-09-04 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
|
KR20210121137A
(ko)
|
2019-01-29 |
2021-10-07 |
샤이어-엔피에스 파마슈티칼즈, 인크. |
부갑상선 호르몬 변이체
|
|
CN118697900A
(zh)
|
2019-01-31 |
2024-09-27 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
|
WO2020183269A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
|
EP3938384A4
(en)
|
2019-03-14 |
2022-12-28 |
Janssen Biotech, Inc. |
PREPARATION PROCEDURES FOR THE PREPARATION OF ANTI-IL12/IL23 ANTIBODY COMPOSITIONS
|
|
KR20210141998A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물의 제조 방법
|
|
EA202192505A1
(ru)
|
2019-03-14 |
2022-03-29 |
Янссен Байотек, Инк. |
Способы получения композиций антитела к фно
|
|
JP2022526493A
(ja)
|
2019-03-18 |
2022-05-25 |
ヤンセン バイオテツク，インコーポレーテツド |
抗ｉｌ１２／ｉｌ２３抗体を用いた小児被験者の乾癬の治療方法
|
|
JP7805788B2
(ja)
|
2019-05-23 |
2026-01-26 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
|
JP2022536279A
(ja)
|
2019-06-03 |
2022-08-15 |
ヤンセン バイオテツク，インコーポレーテツド |
乾癬性関節炎を治療するための抗ｔｎｆ抗体組成物及び方法
|
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
|
MA56124A
(fr)
|
2019-06-04 |
2022-04-13 |
Janssen Biotech Inc |
Méthode sûre et efficace de traitement de l'arthrite psoriasique au moyen d'un anticorps spécifique anti-il23
|
|
US20220280639A1
(en)
|
2019-07-31 |
2022-09-08 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
|
PH12022550110A1
(en)
|
2019-07-31 |
2022-12-12 |
Sk Bioscience Co Ltd |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
|
CA3145580A1
(en)
|
2019-08-09 |
2021-02-18 |
Kaleo, Inc. |
Devices and methods for delivery of substances within a prefilled syringe
|
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
|
US20220372105A1
(en)
|
2019-09-05 |
2022-11-24 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
CN110882447A
(zh)
*
|
2019-11-11 |
2020-03-17 |
徐州深丰精密机械有限公司 |
一种医疗用注射器组件
|
|
CA3158103A1
(en)
|
2019-11-13 |
2021-05-20 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
|
US12161585B2
(en)
|
2019-12-11 |
2024-12-10 |
Eyenovia, Inc. |
Systems and devices for delivering fluids to the eye and methods of use
|
|
AU2020407235A1
(en)
|
2019-12-20 |
2022-07-07 |
Poseida Therapeutics, Inc. |
Anti-MUC1 compositions and methods of use
|
|
CA3169669A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
|
AU2021230361A1
(en)
|
2020-03-04 |
2022-09-08 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of Metabolic Liver Disorders
|
|
WO2021183795A1
(en)
|
2020-03-11 |
2021-09-16 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
|
WO2021211628A1
(en)
|
2020-04-14 |
2021-10-21 |
Poseida Therapeutics, Inc. |
Compositions and methods for use in the treatment of cancer
|
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
|
US20210347880A1
(en)
|
2020-05-05 |
2021-11-11 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
|
IL298389A
(en)
|
2020-05-21 |
2023-01-01 |
Janssen Biotech Inc |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
|
WO2022013745A1
(en)
|
2020-07-13 |
2022-01-20 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
|
US20220073603A1
(en)
|
2020-07-30 |
2022-03-10 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
|
|
US11951284B2
(en)
|
2020-08-27 |
2024-04-09 |
Tandem Diabetes Care, Inc. |
Transitioning to other modes in automated insulin delivery
|
|
US20240000969A1
(en)
|
2020-10-21 |
2024-01-04 |
Poseida Therapeutics San Diego |
Compositions and methods for delivery of nucleic acids
|
|
CN117083065A
(zh)
|
2020-10-30 |
2023-11-17 |
庆应义塾 |
肌肉减少症相关疾病等的新颖治疗和预防
|
|
EP4238979A4
(en)
|
2020-10-30 |
2024-09-25 |
Xeno-Interface Inc. |
BETA-STRAND CROSS-LINKED PEPTIDE
|
|
TW202237068A
(zh)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
製備脂質奈米顆粒的高通量方法及其用途
|
|
US12268847B1
(en)
|
2021-02-10 |
2025-04-08 |
Kaleo, Inc. |
Devices and methods for delivery of substances within a medicament container
|
|
KR102611990B1
(ko)
*
|
2021-02-19 |
2023-12-11 |
(주)바이오시드 |
가스압을 이용한 원터치식 반자동 무침주사기
|
|
EP4298205A1
(en)
|
2021-02-23 |
2024-01-03 |
Poseida Therapeutics, Inc. |
Genetically modified induced pluripotent stem cells and methods of use thereof
|
|
EP4297728A1
(en)
|
2021-02-23 |
2024-01-03 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
|
WO2022187671A1
(en)
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
|
US12433847B2
(en)
|
2021-03-09 |
2025-10-07 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
|
EP4305062A1
(en)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
A safe and effective method for the treatment of rheumatoid arthritis with a specific anti-IL23 antibody
|
|
TW202313065A
(zh)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
用於治療遺傳疾病之化合物
|
|
AR126167A1
(es)
*
|
2021-06-17 |
2023-09-27 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un amortiguador
|
|
US12534524B2
(en)
|
2021-07-09 |
2026-01-27 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-TNF antibody compositions
|
|
JP2024527581A
(ja)
|
2021-07-09 |
2024-07-25 |
ヤンセン バイオテツク，インコーポレーテツド |
抗ｉｌ１２／ｉｌ２３抗体組成物を生産するための製造方法
|
|
EP4367136A1
(en)
|
2021-07-09 |
2024-05-15 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
|
KR102582365B1
(ko)
*
|
2021-08-05 |
2023-09-25 |
(주)씨엔엘바이오텍 |
바늘 없는 주사기형 용기
|
|
CN117615806A
(zh)
|
2021-08-09 |
2024-02-27 |
艾斯曲尔医疗公司 |
制造药物输送装置的子组件的方法
|
|
CN118176204A
(zh)
|
2021-08-11 |
2024-06-11 |
圣诺菲·帕斯图尔公司 |
截短的流感神经氨酸酶及其使用方法
|
|
WO2023039108A1
(en)
|
2021-09-08 |
2023-03-16 |
Affinivax, Inc. |
Coronavirus vaccine
|
|
EP4413141A1
(en)
|
2021-10-04 |
2024-08-14 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
|
CA3234642A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
|
AU2022361432A1
(en)
|
2021-10-08 |
2024-05-23 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines
|
|
EP4423126B1
(en)
|
2021-10-29 |
2026-05-06 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
|
AU2022379948A1
(en)
|
2021-11-05 |
2024-06-20 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
|
EP4433501A1
(en)
|
2021-11-15 |
2024-09-25 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
|
US12171779B2
(en)
|
2021-12-08 |
2024-12-24 |
University Of South Florida |
Regulated drug delivery via controlled degradable chondroitin sulfate particles
|
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
|
US20250084041A1
(en)
|
2021-12-30 |
2025-03-13 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
|
US20250099383A1
(en)
|
2022-01-21 |
2025-03-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
|
JPWO2023145735A1
(https=)
|
2022-01-25 |
2023-08-03 |
|
|
|
JP2025503207A
(ja)
|
2022-01-27 |
2025-01-30 |
サノフィ・パスツール |
修飾されたＶｅｒｏ細胞、及びウイルス産生にこれを使用する方法
|
|
EP4482967A1
(en)
|
2022-02-23 |
2025-01-01 |
Poseida Therapeutics, Inc. |
Genetically modified cells and methods of use thereof
|
|
EP4494146A1
(en)
|
2022-03-14 |
2025-01-22 |
Sanofi Pasteur, Inc. |
Machine-learning techniques in protein design for vaccine generation
|
|
JP2025512860A
(ja)
|
2022-03-30 |
2025-04-22 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｉｌ－２３に特異的な抗体によって軽度から中等度の乾癬を治療する方法
|
|
US20250214046A1
(en)
|
2022-04-01 |
2025-07-03 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
|
EP4526342A1
(en)
|
2022-05-18 |
2025-03-26 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
|
US20250375389A1
(en)
|
2022-07-29 |
2025-12-11 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
|
EP4568990A1
(en)
|
2022-08-11 |
2025-06-18 |
Poseida Therapeutics, Inc. |
Chimeric cd8-alpha co-receptor compositions and methods of use
|
|
CN120152721A
(zh)
|
2022-09-01 |
2025-06-13 |
齐卡尼治疗股份有限公司 |
使用13元大环内酯治疗家族性腺瘤性息肉病
|
|
WO2024091918A2
(en)
|
2022-10-25 |
2024-05-02 |
Modernatx, Inc. |
Methods of lipid nanoparticle production in cross-mixers
|
|
AU2023383916A1
(en)
|
2022-11-22 |
2025-07-10 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|
|
KR20250162510A
(ko)
|
2023-01-20 |
2025-11-18 |
포세이다 테라퓨틱스, 인크. |
리피도이드 화합물 및 관련 조성물 및 용도
|
|
WO2024155931A1
(en)
|
2023-01-20 |
2024-07-25 |
Poseida Therapeutics, Inc. |
Lipidoid compounds and related compositions and uses
|
|
KR20250166122A
(ko)
|
2023-02-21 |
2025-11-27 |
포세이다 테라퓨틱스, 인크. |
게놈 편집을 위한 조성물 및 방법
|
|
EP4669746A1
(en)
|
2023-02-21 |
2025-12-31 |
Poseida Therapeutics, Inc. |
COMPOSITIONS AND GENOMIC EDITING PROCESSES
|
|
KR20250155027A
(ko)
|
2023-02-21 |
2025-10-29 |
포세이다 테라퓨틱스, 인크. |
Aav piggybac 트랜스포존 폴리뉴클레오티드 조성물 및 이의 사용 방법
|
|
EP4689090A1
(en)
|
2023-04-05 |
2026-02-11 |
Poseida Therapeutics, Inc. |
Transposase polynucleotides and uses thereof
|
|
KR20250167671A
(ko)
|
2023-04-05 |
2025-12-01 |
포세이다 테라퓨틱스, 인크. |
키메라 트랜스포사제 및 그의 용도
|
|
AU2024252899A1
(en)
|
2023-04-05 |
2025-11-13 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
|
KR20250167670A
(ko)
|
2023-04-05 |
2025-12-01 |
포세이다 테라퓨틱스, 인크. |
초극소 역위 말단 반복(itr) 서열 및 그의 용도
|
|
EP4705319A1
(en)
|
2023-05-04 |
2026-03-11 |
Affinivax, Inc. |
Rhizavidin variants
|
|
IL324386A
(en)
|
2023-05-10 |
2026-01-01 |
Poseida Therapeutics Inc |
Transposases and uses thereof
|
|
CN121620357A
(zh)
|
2023-06-01 |
2026-03-06 |
赛诺菲巴斯德有限公司 |
包含mRNA脂质纳米颗粒的热稳定组合物
|
|
WO2024259373A1
(en)
|
2023-06-14 |
2024-12-19 |
Modernatx, Inc. |
Compounds and compositions for delivery of therapeutic agents
|
|
WO2025049925A2
(en)
|
2023-09-01 |
2025-03-06 |
Poseida Therapeutics, Inc. |
Lipidoid compounds and related compositions and uses
|
|
WO2025051975A1
(en)
|
2023-09-06 |
2025-03-13 |
Sanofi |
Modified influenza b hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2025064507A1
(en)
|
2023-09-19 |
2025-03-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for integration of viral vectors
|
|
WO2025160127A1
(en)
|
2024-01-23 |
2025-07-31 |
Modernatx, Inc. |
Ionizable lipids and compositions thereof for delivery of therapeutic agents
|
|
WO2025160381A1
(en)
|
2024-01-26 |
2025-07-31 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
WO2025166202A1
(en)
|
2024-01-31 |
2025-08-07 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising sialic acid derivatives and the uses thereof
|
|
WO2025171237A1
(en)
|
2024-02-08 |
2025-08-14 |
Poseida Therapeutics, Inc. |
Lipidoid compounds and related compositions and uses
|
|
WO2025193903A1
(en)
|
2024-03-15 |
2025-09-18 |
Affinivax, Inc. |
Pneumococcal polysaccharide compositions and uses thereof
|
|
CA3249015A1
(en)
|
2024-03-20 |
2025-10-31 |
Janssen Biotech, Inc. |
Methods of treating crohn’s disease with anti-il23 specific antibody
|
|
WO2025262604A1
(en)
|
2024-06-17 |
2025-12-26 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
|
CA3258952A1
(en)
|
2024-06-27 |
2026-03-01 |
Janssen Biotech, Inc. |
Methods of treating ulcerative colitis with anti-il23 specific antibody
|
|
EP4670733A1
(en)
|
2024-06-27 |
2025-12-31 |
Sanofi |
METHODS FOR PREPARING VIRAL PROTEINS AND THEIR USES
|
|
WO2026027730A1
(en)
|
2024-07-31 |
2026-02-05 |
Sanofi |
Modified h5 influenza hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026052773A1
(en)
|
2024-09-06 |
2026-03-12 |
Sanofi |
Modified influenza a hemagglutinin polypeptides and nucleic acids and uses thereof
|
|
WO2026064550A1
(en)
|
2024-09-19 |
2026-03-26 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
|
CN121197586B
(zh)
*
|
2025-10-21 |
2026-04-17 |
中国人民解放军总医院第二医学中心 |
一种具有定位和反馈功能的注射持针装置
|